PS967 PRECLINICAL ACTIVITY OF THE NOVEL ORAL DUAL BET-CBP/P300 INHIBITORS, NEO1132 AND NEO2734, IN ACUTE MYELOID LEUKEMIA Canales, T. Martiañez; van Gils, N.; Vermue, E.; More Canales, T. Martiañez; van Gils, N.; Vermue, E.; Rutten, A.; Denkers, F.; van der Deure, T.; Giles, F.; Smit, L. Less HemaSphere. 3(S1):435-436, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
